Sugi Predict

Sugi Predict / Compounds / SCHEMBL1153692

SCHEMBL1153692

SCHEMBL1153692

COc1ccccc1C(O)(c1ccccc1OC)[C@H](NC(=O)C1(C(=O)N[C@H](c2ccccc2)C(O)(c2ccccc2OC)c2ccccc2OC)CCC1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 4/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MEN1 O00255 6/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ SLC6A9 P48067 1/20 0.36
▸ ITGA4 P13612 5/20 0.36
▸ ITGB7 P26010 5/20 0.36
▸ ITGB1 P05556 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1152551 0.98 L3MBTL1 (0.41) HTTALDH1A1HPGDMEN1KMT2A
SCHEMBL1153308 0.97 L3MBTL1 (0.40) HTTALDH1A1HPGDMEN1KMT2A
SCHEMBL1153344 0.95 ALDH1A1 (0.40) HTTALDH1A1HPGDMEN1KMT2A
SCHEMBL1154023 0.84 L3MBTL1 (0.41) ALDH1A1HPGDMEN1KMT2AL3MBTL1
SCHEMBL1153281 0.83 GAA (0.39) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL808632 0.83 MEN1 (0.43) HTTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL4332813 0.82 ALDH1A1 (0.46) HTTALDH1A1HPGDMEN1KMT2A
SCHEMBL1153971 0.82 L3MBTL1 (0.39) ALDH1A1HPGDMEN1KMT2AL3MBTL1
SCHEMBL1153935 0.82 L3MBTL1 (0.43) ALDH1A1HPGDMEN1KMT2AL3MBTL1
SCHEMBL1153060 0.81 ALDH1A1 (0.41) HTTALDH1A1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943799-B2 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-17 — — US disclosed
US-20110046415-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENEBISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-02-24 — — US disclosed
US-7842839-B2 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-30 — — US disclosed
US-20070112201-A1 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-17 — — US disclosed
EP-1698617-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENE BISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF Sumitomo Chemical Company, Limited (JP) 2006-09-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112201-A1 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof CYP3A7, GRK7, CYP2A7 HTT 3621/4885ALDH1A1 610/4885HPGD 4153/4885
US-20110046415-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENEBISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF CYP3A7, GRK7, CYP2A7 HTT 3621/4885ALDH1A1 610/4885HPGD 4153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.